Delivery Order SPE2DB20D3303-SPE2DB23FZ9C0

Award Date 7/6/23
Potential Completion Date 7/7/23
Potential Value $1.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,603.92 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RENVELA 800 MG TABLET 270S, a medication used to treat hyperphosphatemia. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,167.53, is for the delivery of 270 tablets of the drug Renvela 800 mg. The contract is a firm-fixed-price delivery order, with a period of performance through May 15, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,852.26 delivery order contract is for Renvela 800 mg tablets, a medication used to treat kidney disease. The contract has a firm fixed price and spans from the award date of January 22, 2024 through January 23, 2024. No set-aside designation was used for this award. AmerisourceBergen holds a significant...
This federal contract award, valued at $2,580.07, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award, a delivery order, is for the supply of Renvela 800 mg tablets. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a for-profit organization and a major provider of pharmaceutical products and medical supplies to U.S. government agencies, particularly the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,286.98 Firm Fixed Price Delivery Order is for the supply of RENVELA 2.4 GM POWDER PACKET 90S, a medication used for the treatment of chronic kidney disease. The contract has an ultimate completion date of May 15, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,603.92, is for the delivery of RENVELA 2.4 GM POWDER PACKET 90S, a medication product. The contract has an ultimate completion date of October 22, 2024 and is a firm fixed-price type. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
The Defense Logistics Agency awarded a $1,323 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 180 tablets of 800 mg sevelamer hydrochloride to be delivered from its Conshohocken, Pennsylvania facility by August 30, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform under the contract. No set aside designation or subcontractors were identified. The Defense Logistics Agency is a combat support agency that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,172.47 firm fixed-price delivery order is for the provision of 800 mg Renvela tablets, a medication used to treat kidney disease. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, running through November...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $337.86 to Amerisourcebergen Drug Corporation for 4561558660 SEVELAMER HCL 800 MG TABLET 180S. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the specified pharmaceutical product to a location in Conshohocken, Pennsylvania by July 21, 2023 to support the Defense Logistics Agency's medical supply needs. The parent company, Amerisourcebergen Corporation, will oversee performance through its...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $256.79 to Amerisourcebergen Drug Corporation. The order is for 4561651223 VALSARTAN 80 MG TABLET 90S to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 1, 2023. Amerisourcebergen Drug Corporation is a subsidiary of AmerisourceBergen Corporation, a major pharmaceutical distributor that supports the Department of Defense's supply chain management programs. No subcontractors or...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB23FZ9C0
    Delivery Order

The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $1,449 to Amerisourcebergen Drug Corporation. The order is for 270 tablets of RENVELA 800 MG to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania to an unknown customer by July 7, 2023. Amerisourcebergen Drug Corporation is a subsidiary of AmerisourceBergen Corporation, a major pharmaceutical distributor and logistics services provider that supports the Department of Defense's medical supply needs under various multiple award contracts. No subcontractors or set aside designations were identified in the award information.

Generated 12/20/23, 12:31 AM